Posted by D Anicetti on Jan 9th, 2014
Reversing a negative decision taken back in 2012, the U.S. Food and Drug Administration approved on Wednesday AstraZeneca’s dapagilflozin, which will be sold as Farxiga in the U.S., to help improve the glycemic control, along with...
More of this article »